HoLEP Sheath Sizes for Enlarged Prostate
Trial Summary
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the study team or your doctor.
Research shows that HoLEP is effective for treating benign prostatic hyperplasia (BPH), a common condition in older men, regardless of prostate size. It is considered a minimally invasive procedure with excellent long-term outcomes, making it a new standard for BPH treatment.
12345Research shows that HoLEP is generally safe for treating an enlarged prostate, with studies evaluating its safety and effectiveness over many years and in thousands of patients.
678910HoLEP is unique because it is a minimally invasive treatment that can effectively treat prostates of any size, from small to extremely large, making it a versatile option for benign prostatic hyperplasia (BPH). It uses a laser to remove excess prostate tissue, which can lead to excellent long-term outcomes and is considered the gold standard for surgical treatment of prostate enlargement.
3451112Eligibility Criteria
This trial is for men with benign prostatic hyperplasia (BPH), which means they have an enlarged prostate. The study is looking for participants who haven't had previous treatments that would affect the outcome of this trial.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo Holmium Laser Enucleation of the Prostate (HoLEP) using either a 22F or 26F sheath size
Post-operative Recovery
Participants are monitored for post-operative recovery and same-day discharge
Follow-up
Participants are monitored for continence status, quality of life, and other outcomes
Participant Groups
Holmium Laser Enucleation of the Prostate (HoLEP) is already approved in United States, Canada, European Union for the following indications:
- Benign Prostatic Hyperplasia (BPH)
- Benign Prostatic Hyperplasia (BPH)
- Benign Prostatic Hyperplasia (BPH)